Term
MOA: Balanced Vasodilation
-Decreases LVH > Prolongs Life
-Increases renal blood flow > Diuresis > decr. pulmonary congestion > incr. quality of life
DOC- HF, LVH, DM, post MI systolic dysfunction
Toxicity- CART HH
Cough Angioedema Renal Insufficiency Teratogen Hypotension with first dose HypERkalemia
|
|
Definition
|
|
Term
Use the smallest dose to prevent hypotension
treats systolic dysfunction |
|
Definition
|
|
Term
A 3 of these drugs:
treat heart failure
decrease pulmonary congestion by decreasing preload
diuretics |
|
Definition
Furosemide
Spironolactone
Epleronone |
|
|
Term
causes hypERkalemia
take with captopril since it has short half life |
|
Definition
Spironolactone
Epleronone |
|
|
Term
All 3 of these diuretics reverse cardiac remodeling which prolongs life |
|
Definition
|
|
Term
GFR must be >30 to work
treats hypertension
causes decr. insulin sensitivity
causes muscle weakness |
|
Definition
|
|
Term
Both of these drugs:
cause hypOkalemia
-which worsens Digoxin AEs
To prevent hypOkalemia give with:
ARBs, ACE inhibitors, spironolactone, B blockers, amiloride
or resistrict salt and take potassium supplements |
|
Definition
|
|
Term
MOA: decrease SNS by blocking a1, b1, b2 receptors
decreases contractility > reverses LVH > prolongs life
Balanced Vasodilation > decr. afterload & incr. SV >
incr. EF -- can use in pt's with EF < 35%
decr. HR > incr. filling time> shunts blood to endocardium
salt/water retention > leads to pseudotolerance
decreases automaticity > incr. ERP (most in AV only, sotalol in vent. and atrium also) --> slow conduction |
|
Definition
B blockers
propranolol
atenolol
esmol
sotalol |
|
|
Term
blocks K+ channels> incr. ERP & APD in atria, ventricle, AV node --> TORSADES
DOC for recurrent V. tach
also use to cardiovert people with A. fib |
|
Definition
|
|
Term
treats heart failure
"Start low, go slow"
EF falls initially but then increases |
|
Definition
|
|
Term
DOC for hypertensive emergency |
|
Definition
|
|
Term
use IV
Dysrrhythmia during cardiac catheterization |
|
Definition
|
|
Term
Treat PVCs and tremors from stress |
|
Definition
Propranolol
Other B blockers will work also |
|
|
Term
Treats chronic AVNRT, angina, heart failure, hypertension, v tach |
|
Definition
|
|
Term
MOA: decr. contractility & decr. HR > blocks slow fibers in AV node> incr. ERP in AV node
also decr. SBP, SV, CO, wall tension
incr arterial compliance and blood flow to heart
Treats: Angina, chronic AVNRT
Toxicity- AV block |
|
Definition
|
|
Term
Causes constipation & AV block
Do NOT give with B blocker or Digoxin
|
|
Definition
|
|
Term
Causes AV block
Do NOT give with cimetidine or digoxin |
|
Definition
|
|
Term
MOA: dilate arterioles > decr. afterload = decr. DBP > decr. wall tension and incr. BF to heart and incr. large artery compliance
Treats angina and hypertension
Toxicity- Pedal edema, paradoxical angina
do NOT give with grapefruit juice |
|
Definition
DHP's
Amlodipine
Nefedipine
Fenlodipine |
|
|
Term
A patient comes in with heart failure and A. fib. You want to keep their ventricular rate down. What do you give them? |
|
Definition
|
|
Term
A patient comes in with worsened heart failure. They're on furosemide, lisinopril, dinitrate, hydralazine, spironolactone, carvedilol. What drug should you try next? |
|
Definition
|
|
Term
Apatient comes in with sudden chest pain and a ventricular rate of 200 and you think it might be AVNRT. You give them a drug and the dysrrhythmia goes away-- what drug did you give them?
What drugs should you send them home with? |
|
Definition
Adenosine
Send home with B blocker or verapamil |
|
|
Term
use this drug to diagnose or cardiovert someone with AVNRT to normal rhythm |
|
Definition
|
|
Term
decr. phase 4 automaticity in fast fibers
causes 2 way block to prevent reentry dysrrhythmia
prevents automaticity in ischemic tissue
Treats V. tach, digoxin induced PVCs
Toxicity- seizures |
|
Definition
|
|
Term
MOA- blocks Nain and Kout, noncompetitive a and b blocker, incr. ERP & ADP in atrium, ventricle, AV node
Prolongs PR, QRS, QT
use- cardiovert A. fib, turn Vtach to sinus rhythm, prophylaxis for Vtach
Class III- K channel blocker
toxicity- FATAL pulmonary fibrosis, purple man, thyroid problems |
|
Definition
|
|
Term
decr. preload and afterload and mortality
especially in blacks
|
|
Definition
Isosorbide dinitrate + hydralazine (arterial dilator)
|
|
|
Term
causes SLE-like symptoms
treat heart failure in blacks |
|
Definition
|
|
Term
MOA: NO donor which decreases preload and wall tension
selective venodilation, decr. oxygen demand
slight incr. in myocardial blood flow to reverse ischemia
NO effect on afterload |
|
Definition
Nitrates:
Nitroglycerin
Dinitrate
Mononitrate |
|
|
Term
Causes headaches and orthostatic hypertension
PO form has a potential for tolerance
SL acutely causes incr HR, incr. contractility, decr DBP
sit down while dosing |
|
Definition
|
|
Term
MOA- blocks GI transporter so cholesterol can't be absorbed
does NOT need LDL receptors to lower LDL
2nd choice anti-lipemic drug
|
|
Definition
|
|
Term
MOA: stimulates GPR109A receptor
-decr. TG via lipolysis
-decr. LDL due to decr. VLDL & making bigger LDL particles
-decr. VLDL via ApoB100 degradation
-incr. HDL by preventing the liver from destroying HDL-ApoA> incr. direct pathway to reverse chol. transport
used to treat people with mixed hyperlipidemias (incr. LDL & TG)
Toxicities- flushing and pruritis at start. aspirin laropiprant helps by blocking PGD2
DON'T give with statin- worsens myopathy |
|
Definition
|
|
Term
MOA: ion exchange resins. causes bile acids to be lost in feces> more chol is used to make bile thus decr. pool
Effect- decr. LDL ONLY
Toxicities- constipation
decreases bioavailability of warfarin & pravastatin |
|
Definition
Bile Acid Binders:
Cholestyramine
Colestipol
Colesevelam |
|
|
Term
used to lower LDL in pt w/ CV risk
does not affect bioavailability of other drugs
safe in preg. women
take 6 pills/day |
|
Definition
|
|
Term
MOA: binds to PPARa
-decr. TG by stimulating PPARa > incr. VLDL clearance & decr. VLDL synthesis
-decr. VLDL by reducing ApoCIII expression and incr. lipase synthesis
-decr. LDL by incr. SREBP synth > incr. LDL rec's
-incr. HDL by incr. ApoA1 synth.
Use in diabetics- esp. for VLDL and HDL
|
|
Definition
Fibrates:
Fenofibrate
Gemfibrozil |
|
|
Term
MOA: HMG CoA reductase inhibitor > can't make cholesterol > incr. LD rec's
Increases cholesterol plaque stability
Toxicities- myositis, teratogen, fatal rhabdomyolysis |
|
Definition
Statins:
Simvastatin
Pravastatin
Atorvastatin
Rosuvastatin |
|
|
Term
Which 2 statins are NOT metabolized by cytochrome P450? |
|
Definition
|
|
Term
MOA: cleaves plasminogen to form plasmin
degrades everything in site, including factors 5, 8, fibrinogen
use- MI, PE, DVT, stroke
Antidote- Aminocaproic Acid
|
|
Definition
Fibrinolytics:
TPA
Alteplase
Streptokinase |
|
|
Term
MOA: prevents vitamin K from being reduced > factors 2, 5, 7, 9, 10 can't get made
Treat- DVT, prevent thromboembolism in A. fib and prosthetic valves
Toxicities- teratogenic, metab. by P450
Antibiotics increase its activity due to destroying gut flora
increases INR
Antidote- phytonadione |
|
Definition
|
|
Term
MOA1- anti-platelets- makes wall neg. so platelets can't bind> incr. bleeding time
MOA2- anti-coagulant- binds to ATIII to inhibit clotting factors 2, 9-12
Use: DVT prophylaxis, treat DVT & PE, history of thrombosis, during pregnancy
half life increases as dose is increased
use PTT to measure activity
Antidote- protamine sulfate |
|
Definition
|
|
Term
What causes heparin resistance? |
|
Definition
1. PE increases heparin clearance
2. Congenital ATIII deficiency
3. Acquired ATIII deficiency- cirrhosis, nephrotic syndrome, DIC
4. Acute phase proteins |
|
|
Term
MOA: binds ATIII to inhibit factor 10
Use: DVT prophylaxis, stroke, ACS, dialysis
|
|
Definition
LMW heparins:
Ardeparin
Dalteparin
Enoxaparin |
|
|
Term
MOA- binds to ATIII to inhibit factors 2, 9-12
Use: DVT, PE, HIT |
|
Definition
|
|
Term
Direct inhibitor of factor 10
Use- DVT
Toxicity- BLEEDING
Metabolized by P450
|
|
Definition
|
|
Term
MOA- direct, irreversible inhibitor of 2a
Use- HIT
|
|
Definition
|
|
Term
take IV
MOA- Direct, reversible inhibitor of 2
Use- HIT, DVT
Increases INR when given with warfarin |
|
Definition
|
|
Term
MOA- direct reversible inhibitor of 2
Use- prevents thrombosis in A. fib
Toxicity- gastritis & dyspepsia |
|
Definition
Dabigatran
Eating da big mac can give you dyspepsia
|
|
|
Term
irreversible COX1 inhibitor
prevents TXA2 production
increases bleeding time |
|
Definition
|
|
Term
MOA- blocks II/III receptor so nothing can bind to platelet including fibrinogen
Use- PCI, ACS- MI or unstable angina
incr. bleeding time |
|
Definition
TEA
Tirofiban
Eptifibatide
Abciximib |
|
|
Term
Monoclonal antibody- irreversibly blocks II/III receptor so nothing can bind to platelets |
|
Definition
|
|
Term
Competitive inhibitors of II/III receptor |
|
Definition
|
|
Term
MOA- blocks the P2Y(12) receptor that ADP binds to> platelets can't aggregate
Use- with aspirin to prevent MI or stroke
-if you have an aspirin hypersensitivity
-secondary prevention of stroke
incr. bleeding time |
|
Definition
|
|
Term
Anti-platelet med
causes neutropenia
give 10 days to get full effect |
|
Definition
|
|
Term
Irreversible inhibitor of P2Y(12) receptor |
|
Definition
|
|
Term
Same MOA as ACE inhibitors
Balanced Vasodilators
Angiotensin II receptor blockers
Increases compliance of small and larger arteries
Use- hypertension and heart failure
Toxicity- teratogenic, angioedema, hyperkalemia, hypotension
|
|
Definition
|
|
Term
What do you treat hypertensive kids and pregnant women with?
Toxicity- sedation, dry mouth, rebound hypertension |
|
Definition
|
|
Term
a2 adrenocceptor agonist in brain> reduces sympathetic outflow
balanced vasodilation
incr. FF > salt/water retention> pseudotolerance
decreases rening and angII
Use- Hypertension
Toxicity- vivid dreams, orthostatic intolerance
withdrawal syndrome- incr. BP, tremor |
|
Definition
|
|
Term
MOA: NO dilates arteries and inhibits platelet aggregation
Balanced vasodilator
Use: hypertensive emergencies in SUPINE patients
stops dissecting aortic aneurysm
Super short half-life (30s) |
|
Definition
|
|
Term
Only use if other drugs haven't been able to decrease their hypertension
MOA: vasodilates resistance arterioles>
incr. HR, incr CO> take with B blocker
causes salt/water retention |
|
Definition
Hydralazine
Minoxidil
Diazoxide |
|
|
Term
causes hairiness= hypertrichosis
also causes edema, angina |
|
Definition
|
|
Term
Which hemodynamic values get changed:
MOA:
Antidote:
Aspirin |
|
Definition
incr. BT
TXA2 via irreversible COX1 inhibitor
none |
|
|
Term
Which hemodynamic values get changed:
MOA:
Antidote:
abciximab
eptifibatide
tirofiban |
|
Definition
|
|
Term
Which hemodynamic values get changed:
MOA:
Antidote:
clopidogrel
ticlopidine
|
|
Definition
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Heparin
|
|
Definition
incr. BT, incr. PTT
2, 9-12
ATIII
Protamine sulfate
|
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Ardeparin
Dalteparin
Enoxaparin |
|
Definition
no changes
10
ATIII
Protamine sulfate- partial |
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Fondaparinux sc
|
|
Definition
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Rivaroxaban
|
|
Definition
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Lepirudin IV |
|
Definition
incr. PTT
2a
Direct and IRREVERSIBLE
None |
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Argatroban
|
|
Definition
incr. PTT
2
Direct
none
may incr. INR when given with warfarin |
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Dabigatran
|
|
Definition
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
warfarin po- normal dose
|
|
Definition
incr. INR (PT)
2, 7, 9, 10
Decr. Vit KH2
Phytonadione |
|
|
Term
Which hemodynamic values get changed:
Clotting factors:
MOA:
Antidote:
Side effects:
warfarin po- overdose |
|
Definition
incr PTT and INR (PT)
2, 7, 9, 10
decr. vitKH2
phytonadione
causes PACs, PVCs, AV block, affects green-yellow vision |
|
|
Term
Name the 4 groups of drugs that increase bleeding time: |
|
Definition
Anti-platelets:
Aspirin
II/III inhibitors- tiro, epti, abc
P2y(12) inhibitors- ticlopidine, clopidogrel
Heparin |
|
|
Term
Name the 4 drugs that can increase PTT |
|
Definition
Factor 2 inhibitors:
LAD + warfarin overdose
Lepirudin
Argatroban
Dabigatran |
|
|
Term
Name the drug that increases PT (INR) |
|
Definition
Warfarin
--increased further by argatroban |
|
|
Term
Name the 7 drugs that inhibit factor 10 |
|
Definition
FADE With Hot Rain
Fondaparinux
Ardeparin
Dalteparin
Enoxaparin
Warfarin
Heparin
Rivaroxaban
|
|
|
Term
Name the 4 drugs that only inhibit factor 10 thru ATIII |
|
Definition
FADE
Fondaparinux + LMW heparins
Ardeparin
Dalteparin
Enoxaparin |
|
|
Term
Slow: Which drugs decrease conduction throught the AV node?
Fast: Which drugs decrease ventricular conduction?
Which decrease automaticity in both? |
|
Definition
1. Verapamil, Digoxin, Adenosine
2. Lidocaine
3. B blockers incl. Sotalol, Amiodarone |
|
|
Term
Which drugs cause salt and water retention? |
|
Definition
B blockers
Clonidine
Hydralazine, Minoxidil, Diazoxide |
|
|
Term
Name 4 causes of resistance to warfarin: |
|
Definition
1. Cytochrome P450
2. Hypoalbuminemia- nephrotic syndrome
3. Anion exchange resins like cholestyramine, colestipol
4. Increased K intake |
|
|
Term
Which drug causes Torsades? |
|
Definition
|
|
Term
|
Definition
B blockers
Digoxin
Verapamil, Dilt |
|
|
Term
|
Definition
SL NTG
Hydralazine, Minoxidil, Diazoxide |
|
|
Term
1. Drugs that cause hypOkalemia
2. Drugs that cause hypERkalemia |
|
Definition
1. HCTZ, Furosemide
2. Spiro/Epleronone, ACEinhibitors/ARBs |
|
|
Term
How do you treat people with cyanide toxicity due to sodium nitroprusside? |
|
Definition
|
|
Term
What makes digoxin toxicity worse? |
|
Definition
low K, hyperaldosteronism
low Mg, HIGH Ca
Slow conductors: B blockers, Verapamil
Spironolactone- decreases renal clearance
|
|
|
Term
What is the DOC for acute V fib? |
|
Definition
|
|
Term
What is the DOC for chronic V fib |
|
Definition
|
|
Term
How do statins lower LDL? |
|
Definition
By competitively inhibiting HMG CoA reductase |
|
|
Term
What is the MOA of lidocaine? |
|
Definition
"stuns" the heart so it can't react to other drugs (ie digoxin)
1. suppresses ventricular automaticity > decreases spontaneous phase 4 depolarization in ischemic/digoxin tissue > decr. PVCs in ischemic tissue
2. causes 2 way block to stop reentry v. tach
3. increases threshold potential to further suppress automaticity
--no effect on AV conduction and no effect on EKG |
|
|
Term
Which drug is associated with sedation? |
|
Definition
|
|
Term
Which drugs block AV node only? |
|
Definition
Verapamil- directly
Digoxin- via vagal stimulation
Adenosine |
|
|
Term
Which drugs prevent PVCs? |
|
Definition
|
|
Term
Which drugs block AV node, atrium, ventricle? |
|
Definition
|
|
Term
Which drugs cause salt/water retention? |
|
Definition
B blockers
Clonidine
Hydralazine, Minoxidil, Diazoxide |
|
|
Term
|
Definition
B blockers
Verapamil
Digoxin |
|
|
Term
|
Definition
SL Nitro- acutely
Hydralazine, Minoxidil, Diazoxide
Slight- Sodium Nitroprusside, Nifedipine, Amlodipine, Felodipine |
|
|
Term
|
Definition
|
|
Term
|
Definition
Spiro/Epleronone
ACE inhibitors/ARBs |
|
|
Term
|
Definition
I'll pay CASH just for some balanced vasodilation
Clonidine
ACE inhibitors/ARBs
Sodium Nitroprusside
Hydralazine + Dinitrate
|
|
|
Term
Increase Arterial Compliance |
|
Definition
ACEinhibitors/ARBs
Dihydropyridines |
|
|